A recent study, published in the Archives of Internal Medicine, found that the cholesterol-lowering drugs known as statins increase the risk of diabetes within postmenopausal women by 48%. This new finding adds to a growing body of clinical evidence that statin drugs are fundamentally diabetogenic, which is not surprising considering the National Library of Medicine contains peer-reviewed, published research on over 300 other known adverse effects associated with their use.
Marking the beginning of another dark chapter in the history of medicine, The American National Heart, Lung, and Blood Institute (NHLBI), via the American Heart Association and the American College of Cardiology have just announced a radical change to the way that statins will now be prescribed.
Over 30 billion dollars worth of this drug is sold annually and yet it may be benefiting no one. In fact, there are over 300 adverse effects associated with its use, not the least of which is the weakening of the heart muscle. In order to cover-up the symptoms of statin-induced muscle damage new "diseases" have been coined, including polymyalgia rheumatica.